References
- Loffeld RJLF, van der Putten ABMM. Rising incidence of reflux oesophagitis in patients undergoing upper gastrointestinal endoscopy. Digestion 2003; 68: 141–4
- Werdmuller B, van der Putten ABMM, Loffeld RJLF. The presentation of reflux esophagitis, hiatal hernia, Barrett's esophagus and “reflux-like” dyspepsia: a prospective clinical and endoscopic study. Dis Esophagus 1996; 9: 285–9
- Loffeld RJLF. Young patients with Barrett's oesophagus experience less reflux complaints. Digestion 2001; 64: 151–4
- Loffeld RJLF. Reflux complaints, symptom score, and use of medication in patients with reflux esophagitis, results of a long-term follow-up study. Can J Gastroenterol 2001; 15: 505–8
- Boom HD, Loffeld RJLF. Long-term use of acid suppressive therapy after endoscopic diagnosis of reflux esophagitis. Dis Esophagus 2000; 13: 271–4
- Bardhan KD, Stanghellini V, Armstrong D, Berghöfer P, Gatz G, Mönnikes H. Evaluation of GERD symptoms during therapy. Part 1: Development of the new GERD questionnaire ReQuest™. Digestion 2004; 69: 229–37
- Mönnikes H, Bardhan KD, Stanghellini V, Berghöfer P, Bethke TD, Armstrong D. Evaluation of GERD symptoms during therapy. Part II: Psychometric evaluation and validation of the new questionnaire ReQuest™ in erosive GERD?. Digestion 2004; 69: 238–44
- Bardhan KD, Stanghellini V, Armstrong D, Berghöfer P, Gatz G, Mönnikes H. International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004; 20: 891–8